These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3025406)

  • 41. Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.
    Chen RJ; Jinn TR; Chen YC; Chung TY; Yang WH; Tzen JT
    Acta Pharmacol Sin; 2011 Feb; 32(2):141-51. PubMed ID: 21293466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.
    Almotrefi AA; Dzimiri N
    Br J Pharmacol; 1991 Dec; 104(4):793-6. PubMed ID: 1667285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac glycosides and sodium/potassium-ATPase.
    Greeff K; Fox AA
    Basic Res Cardiol; 1984; 79 Suppl():16-20. PubMed ID: 6331375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A new class of cardiotonic steroids].
    Kamernitskiĭ AV; Kutnevich IA; Reshetova IG; Chernoburova EI; Gorshkov BA; Gorshkova IA; Kapustina II
    Bioorg Khim; 1991 Jan; 17(1):141-3. PubMed ID: 1648353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of modifying potassium concentration on the inhibition of myocardial Na(+)-K(+)-ATPase by two class IB antiarrhythmic drugs: lidocaine and tocainide.
    Almotrefi AA; Dzimiri N
    Gen Pharmacol; 1991; 22(6):1097-101. PubMed ID: 1667301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The inhibition of the Na-K-ATPase of guinea-pig heart microsomes by cardiac glycosides.
    Godfraind T; De Pover A
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):197-200. PubMed ID: 4268671
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiac glycosides with different effects in the heart.
    Lüllmann H; Peters T; Prillwitz HH; Ziegler A
    Basic Res Cardiol; 1984; 79 Suppl():93-101. PubMed ID: 6331383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac glycosides. 7. Sugar stereochemistry and cardiac glycoside activity.
    Rathore H; From AH; Ahmed K; Fullerton DS
    J Med Chem; 1986 Oct; 29(10):1945-52. PubMed ID: 3020248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The thermodynamic essence of the reversible inactivation of Na+/K+-transporting ATPase by various digitalis derivatives is relaxation of enzyme conformational energy.
    Beer J; Kunze R; Herrmann I; Portius HJ; Mirsalichova NM; Abubakirov NK; Repke KR
    Biochim Biophys Acta; 1988 Jan; 937(2):335-46. PubMed ID: 2827773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of potassium concentration on the inhibitory effect of amiodarone on guinea-pig microsomal Na(+)-K(+)-ATPase activity.
    Almotrefi AA; Dzimiri N
    Pharmacol Toxicol; 1991 Aug; 69(2):140-3. PubMed ID: 1663618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
    Schwalb H; Dickstein Y; Heller M
    Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
    [No Abstract]   [Full Text] [Related]  

  • 52. Inotropic actions of doxorubicin in isolated guinea-pig atria: evidence for lack of involvement of Na+,K+-adenosine triphosphatase.
    Kim DH; Akera T; Brody TM
    J Pharmacol Exp Ther; 1980 Aug; 214(2):368-74. PubMed ID: 6248634
    [No Abstract]   [Full Text] [Related]  

  • 53. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of myocardial Na(+)-K(+)-ATPase activity by bretylium: role of potassium.
    Dzimiri N; Almotrefi AA
    Arch Int Pharmacodyn Ther; 1992; 318():76-85. PubMed ID: 1334399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (Na+, K+)-ATPase in the myocardium.
    Gibson K
    Acta Cardiol; 1973; ():Suppl 17:41-51. PubMed ID: 4271961
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of (Na/K)-ATPase by electrophilic substances: functional implications.
    Breier A; Ziegelhöffer A; Stankovicová T; Docolomanský P; Gemeiner P; Vrbanová A
    Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):187-92. PubMed ID: 7494549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart.
    Erdmann E; Philipp G; Scholz H
    Biochem Pharmacol; 1980 Dec; 29(24):3219-29. PubMed ID: 6260108
    [No Abstract]   [Full Text] [Related]  

  • 58. Digitalis genin activity: side-group carbonyl oxygen position is a major determinant.
    Fullerton DS; Yoshioka K; Rohrer DC; From AH; Ahmed K
    Science; 1979 Aug; 205(4409):917-9. PubMed ID: 224455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on cardioactive steroids. IV. Influence of nitrate ester formation on cardiac and extracardiac activity.
    Haustein KO; Glusa E; Megges R
    Pharmacology; 1980; 20(1):15-20. PubMed ID: 7375498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac glycosides and intracellular Na+, K+, Ca2+.
    Noack E
    Basic Res Cardiol; 1984; 79 Suppl():87-92. PubMed ID: 6331382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.